JW Pharmaceutical Corporation 001065.KS Stock
JW Pharmaceutical Corporation Price Chart
JW Pharmaceutical Corporation 001065.KS Financial and Trading Overview
| JW Pharmaceutical Corporation stock price | 28850 KRW |
| Previous Close | 31850 KRW |
| Open | 31850 KRW |
| Bid | 31500 KRW x 0 |
| Ask | 31850 KRW x 0 |
| Day's Range | 31600 - 31950 KRW |
| 52 Week Range | 28900 - 37350 KRW |
| Volume | 101 KRW |
| Avg. Volume | 268 KRW |
| Market Cap | 777B KRW |
| Beta (5Y Monthly) | 0.246917 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | 388.35 (1.23%) |
| Ex-Dividend Date | December 28, 2022 |
| 1y Target Est | N/A |
001065.KS Valuation Measures
| Enterprise Value | 842.58B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.1077883 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1.201 |
| Enterprise Value/EBITDA | 9.748 |
Trading Information
JW Pharmaceutical Corporation Stock Price History
| Beta (5Y Monthly) | 0.246917 |
| 52-Week Change | -13.45% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 37350 KRW |
| 52 Week Low | 28900 KRW |
| 50-Day Moving Average | 31867 KRW |
| 200-Day Moving Average | 33210.02 KRW |
001065.KS Share Statistics
| Avg. Volume (3 month) | 268 KRW |
| Avg. Daily Volume (10-Days) | 375 KRW |
| Shares Outstanding | 20.1M |
| Float | 12.98M |
| Short Ratio | N/A |
| % Held by Insiders | 635.41% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | 107.00% |
| Payout Ratio | N/A |
| Last Split Factor | 1.03:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 5.39% |
| Operating Margin (ttm) | 9.64% |
| Gross Margin | 42.68% |
| EBITDA Margin | 12.32% |
Management Effectiveness
| Return on Assets (ttm) | 6.46% |
| Return on Equity (ttm) | 16.88% |
Income Statement
| Revenue (ttm) | 701.39B KRW |
| Revenue Per Share (ttm) | 31391.98 KRW |
| Quarterly Revenue Growth (yoy) | 10.90% |
| Gross Profit (ttm) | 287.95B KRW |
| EBITDA | 86.43B KRW |
| Net Income Avi to Common (ttm) | 37.33B KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | 62.00% |
Balance Sheet
| Total Cash (mrq) | 135.76B KRW |
| Total Cash Per Share (mrq) | 6019 KRW |
| Total Debt (mrq) | 281.43B KRW |
| Total Debt/Equity (mrq) | 120.42 KRW |
| Current Ratio (mrq) | 1.08 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 51.24B KRW |
| Levered Free Cash Flow (ttm) | 33.36B KRW |
Profile of JW Pharmaceutical Corporation
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | 2477, Nambusunhwan-ro |
| ZIP | 137-864 |
| Phone | 82 2 840 6777 |
| Website | https://www.jw-pharma.co.kr |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cardiovascular, gastrointestinal, urinary, oral hypoglycemic, antibiotics, anti-fungal, Ob and Gy, renal, CNS, anti-anemic, respiratory, rheumatic arthritis, anticancer, anesthetic, antidotes, amino acids, TPN, and others. The company was founded in 1945 and is headquartered in Seoul, South Korea.
Q&A For JW Pharmaceutical Corporation Stock
What is a current 001065.KS stock price?
JW Pharmaceutical Corporation 001065.KS stock price today per share is 28850 KRW.
How to purchase JW Pharmaceutical Corporation stock?
You can buy 001065.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for JW Pharmaceutical Corporation?
The stock symbol or ticker of JW Pharmaceutical Corporation is 001065.KS.
Which industry does the JW Pharmaceutical Corporation company belong to?
The JW Pharmaceutical Corporation industry is Drug Manufacturers-Specialty & Generic.
How many shares does JW Pharmaceutical Corporation have in circulation?
The max supply of JW Pharmaceutical Corporation shares is 24.32M.
What is JW Pharmaceutical Corporation Price to Earnings Ratio (PE Ratio)?
JW Pharmaceutical Corporation PE Ratio is now.
What was JW Pharmaceutical Corporation earnings per share over the trailing 12 months (TTM)?
JW Pharmaceutical Corporation EPS is 0 KRW over the trailing 12 months.
Which sector does the JW Pharmaceutical Corporation company belong to?
The JW Pharmaceutical Corporation sector is Healthcare.